{"transactions":[{"id":286,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-02T20:00:27.000Z","date":"2026-08-31","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.05,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-380152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1969821/000119312526380152/ownership.xml","form_type":"4"}},{"id":285,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-02T20:00:27.000Z","date":"2026-08-31","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-380152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1969821/000119312526380152/ownership.xml","form_type":"4"}},{"id":284,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T20:00:27.000Z","date":"2026-08-31","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":5.05,"value":126250.0,"ownership":{"direct":true},"balance_after":116900,"source":{"system":"sec-edgar","filing":"0001193125-26-380152","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1969821/000119312526380152/ownership.xml","form_type":"4"}},{"id":283,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T20:00:27.000Z","date":"2026-08-31","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":1.76,"value":44000.0,"ownership":{"direct":true},"balance_after":91900,"source":{"system":"sec-edgar","filing":"0001193125-26-380152","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1969821/000119312526380152/ownership.xml","form_type":"4"}},{"id":746150,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-08T20:00:11.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":24372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":24372,"derivative":{"exercise_price":14.31,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":24372},"source":{"system":"sec-edgar","filing":"0001193125-26-261641","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526261641/ownership.xml","form_type":"4"}},{"id":763718,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T20:00:07.000Z","date":"2026-05-21","kind":"purchase","planned":false,"acquired":true,"shares":3800,"price":13.51,"value":51338.0,"ownership":{"direct":true},"balance_after":66900,"source":{"system":"sec-edgar","filing":"0001193125-26-239216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526239216/ownership.xml","form_type":"4"}},{"id":959597,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-24T01:48:33.000Z","date":"2025-12-23","kind":"purchase","planned":false,"acquired":true,"shares":8100,"price":12.45,"value":100845.0,"ownership":{"direct":true},"balance_after":63100,"source":{"system":"sec-edgar","filing":"0001193125-25-331289","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312525331289/ownership.xml","form_type":"4"}},{"id":1117866,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:08:39.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":5.05,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-25-083719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000095017025083719/ownership.xml","form_type":"4"}},{"id":1411848,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-09T20:05:06.000Z","date":"2024-09-05","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":2.1318,"value":106590.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.11 to $2.15. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."}],"balance_after":55000,"source":{"system":"sec-edgar","filing":"0000950170-24-104737","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000095017024104737/ownership.xml","form_type":"4"}},{"id":1486748,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T20:50:46.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-070804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000095017024070804/ownership.xml","form_type":"4"}},{"id":1704872,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-19T21:37:26.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":14.97,"value":59880.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000950170-23-071533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000095017023071533/ownership.xml","form_type":"4"}},{"id":1858770,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T23:50:05.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":3908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 8, 2024 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":3908,"derivative":{"exercise_price":26.25,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":3908},"source":{"system":"sec-edgar","filing":"0000899243-23-015412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323015412/doc4.xml","form_type":"4"}},{"id":1944495,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-21T00:22:25.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":27403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to the option shall vest on the first anniversary of the date of grant, and the remaining two-thirds will vest in equal monthly installments over two years, provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director of the Issuer."}],"balance_after":27403,"derivative":{"exercise_price":32.08,"expiration_date":"2033-03-16","underlying":"Common Stock","underlying_shares":27403},"source":{"system":"sec-edgar","filing":"0000899243-23-009172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323009172/doc4.xml","form_type":"4"}},{"id":1944494,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":260,"kind":"person","name":"Firestone Karen","position":1,"cik":"0001969821","reported_name":"Firestone Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-21T00:22:25.000Z","date":"2023-03-16","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":31.99,"value":31990.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.96 to $32.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request"}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000899243-23-009172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323009172/doc4.xml","form_type":"4"}}]}